WASHINGTON — Federal regulators have approved the first alternative version of the second-biggest selling drug in the world, AbbVie’s Humira, a blockbuster injection used to treat rheumatoid arthritis ...
CVS Health Inc. (NYSE: CVS) on Thursday said it is taking additional steps to lower prescription drug costs by expanding access to biosimilar medications, announcing new formulary changes that will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results